CN104140949A - 囊胚培养液及其制备方法 - Google Patents
囊胚培养液及其制备方法 Download PDFInfo
- Publication number
- CN104140949A CN104140949A CN201410388960.XA CN201410388960A CN104140949A CN 104140949 A CN104140949 A CN 104140949A CN 201410388960 A CN201410388960 A CN 201410388960A CN 104140949 A CN104140949 A CN 104140949A
- Authority
- CN
- China
- Prior art keywords
- culture liquid
- blastocyst culture
- blastocyst
- stoste
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002459 blastocyst Anatomy 0.000 title claims abstract description 71
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 13
- 102000008100 Human Serum Albumin Human genes 0.000 claims abstract description 14
- 108091006905 Human Serum Albumin Proteins 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 79
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 14
- 210000001161 mammalian embryo Anatomy 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 238000012360 testing method Methods 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000002158 endotoxin Substances 0.000 claims description 8
- 235000020776 essential amino acid Nutrition 0.000 claims description 8
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical group C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 7
- 230000003204 osmotic effect Effects 0.000 claims description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 7
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 7
- 239000012498 ultrapure water Substances 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 6
- 229930182566 Gentamicin Natural products 0.000 claims description 6
- 230000003013 cytotoxicity Effects 0.000 claims description 6
- 231100000135 cytotoxicity Toxicity 0.000 claims description 6
- 229960002518 gentamicin Drugs 0.000 claims description 6
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 6
- 206010070834 Sensitisation Diseases 0.000 claims description 5
- 230000008313 sensitization Effects 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 235000004279 alanine Nutrition 0.000 claims description 4
- 239000003797 essential amino acid Substances 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 238000005374 membrane filtration Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 230000000638 stimulation Effects 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- QWWVBNODQCWBAZ-WHFBIAKZSA-N (2r)-2-amino-3-[(2r)-2-carboxy-2-(methylamino)ethyl]sulfanylpropanoic acid Chemical compound CN[C@H](C(O)=O)CSC[C@H](N)C(O)=O QWWVBNODQCWBAZ-WHFBIAKZSA-N 0.000 claims description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 235000019743 Choline chloride Nutrition 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
- -1 D-VB5 Chemical compound 0.000 claims description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 239000007995 HEPES buffer Substances 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 2
- 229930064664 L-arginine Natural products 0.000 claims description 2
- 235000014852 L-arginine Nutrition 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- 229930195722 L-methionine Natural products 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 2
- 108010044940 alanylglutamine Proteins 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 229960003178 choline chloride Drugs 0.000 claims description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- DBLXOVFQHHSKRC-UHFFFAOYSA-N ethanesulfonic acid;2-piperazin-1-ylethanol Chemical compound CCS(O)(=O)=O.OCCN1CCNCC1 DBLXOVFQHHSKRC-UHFFFAOYSA-N 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 229960002885 histidine Drugs 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229960004452 methionine Drugs 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 229960003581 pyridoxal Drugs 0.000 claims description 2
- 235000008164 pyridoxal Nutrition 0.000 claims description 2
- 239000011674 pyridoxal Substances 0.000 claims description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 2
- 235000008160 pyridoxine Nutrition 0.000 claims description 2
- 239000011677 pyridoxine Substances 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- NGSFWBMYFKHRBD-UHFFFAOYSA-N sodium;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O NGSFWBMYFKHRBD-UHFFFAOYSA-N 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- 229960002898 threonine Drugs 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 230000001850 reproductive effect Effects 0.000 abstract description 3
- 238000000338 in vitro Methods 0.000 abstract description 2
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000012797 qualification Methods 0.000 description 4
- 239000013642 negative control Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002510 pyrogen Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 101100515508 Arabidopsis thaliana XI-D gene Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010042573 Superovulation Diseases 0.000 description 1
- 241000239222 Tachypleus Species 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
项目 | 配方1 | 配方2 | 配方3 | 配方4 |
pH值 | 7.2 | 7.3 | 7.3 | 7.2 |
渗透压mOsm/Kg | 269 | 275 | 280 | 285 |
细胞毒性 | 合格 | 合格 | 合格 | 合格 |
皮内刺激 | 无皮内刺激 | 无皮内刺激 | 无皮内刺激 | 无皮内刺激 |
致敏 | 无致敏反应 | 无致敏反应 | 无致敏反应 | 无致敏反应 |
热原 | 无热原 | 无热原 | 无热原 | 无热原 |
无菌检测 | 无菌 | 无菌 | 无菌 | 无菌 |
细菌内毒素检测 | 合格 | 合格 | 合格 | 合格 |
体外鼠胚试验 | 囊胚合格率85% | 囊胚合格率87% | 囊胚合格率82% | 囊胚合格率85% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410388960.XA CN104140949B (zh) | 2014-08-08 | 2014-08-08 | 囊胚培养液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410388960.XA CN104140949B (zh) | 2014-08-08 | 2014-08-08 | 囊胚培养液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104140949A true CN104140949A (zh) | 2014-11-12 |
CN104140949B CN104140949B (zh) | 2017-10-03 |
Family
ID=51850291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410388960.XA Active CN104140949B (zh) | 2014-08-08 | 2014-08-08 | 囊胚培养液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104140949B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105145545A (zh) * | 2015-07-27 | 2015-12-16 | 北京泛生子生物科技有限公司 | 用于常温条件下长期保存和运输组织样本的核酸保护液 |
CN107118261A (zh) * | 2017-05-12 | 2017-09-01 | 南京市妇幼保健院 | 一种胚胎分泌型内源性多肽pdbcm及其应用 |
CN107254433A (zh) * | 2017-05-24 | 2017-10-17 | 瑞柏生物(中国)股份有限公司 | 一种胚胎移植胶及其制备方法 |
CN108251353A (zh) * | 2018-01-22 | 2018-07-06 | 深圳韦拓生物科技有限公司 | 一种人胚胎体外培养液及培养系统 |
CN108753690A (zh) * | 2018-06-05 | 2018-11-06 | 瑞柏生物(中国)股份有限公司 | 一种一步培养液及其制备方法 |
CN108753691A (zh) * | 2018-06-05 | 2018-11-06 | 瑞柏生物(中国)股份有限公司 | 一种囊胚培养液及其制备方法 |
CN108823150A (zh) * | 2018-05-16 | 2018-11-16 | 瑞柏生物(中国)股份有限公司 | 一种输卵管缓冲培养液及其制备方法 |
CN110669724A (zh) * | 2019-11-08 | 2020-01-10 | 广州达瑞生殖技术有限公司 | 一种囊胚培养液及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101679944A (zh) * | 2007-05-01 | 2010-03-24 | 维特罗莱夫瑞典有限公司 | 用于发育细胞的含有高浓度硫辛酸的培养基 |
CN102703381A (zh) * | 2012-06-30 | 2012-10-03 | 郑州大学第一附属医院 | 一种利用人体废弃胚胎建立人胚胎干细胞系的方法 |
-
2014
- 2014-08-08 CN CN201410388960.XA patent/CN104140949B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101679944A (zh) * | 2007-05-01 | 2010-03-24 | 维特罗莱夫瑞典有限公司 | 用于发育细胞的含有高浓度硫辛酸的培养基 |
CN102703381A (zh) * | 2012-06-30 | 2012-10-03 | 郑州大学第一附属医院 | 一种利用人体废弃胚胎建立人胚胎干细胞系的方法 |
Non-Patent Citations (1)
Title |
---|
王敏康 等: ""几种克服昆明小鼠2-细胞胚胎发育阻滞的培养液研究"", 《动物学报》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105145545A (zh) * | 2015-07-27 | 2015-12-16 | 北京泛生子生物科技有限公司 | 用于常温条件下长期保存和运输组织样本的核酸保护液 |
CN107118261A (zh) * | 2017-05-12 | 2017-09-01 | 南京市妇幼保健院 | 一种胚胎分泌型内源性多肽pdbcm及其应用 |
CN107254433A (zh) * | 2017-05-24 | 2017-10-17 | 瑞柏生物(中国)股份有限公司 | 一种胚胎移植胶及其制备方法 |
CN108251353A (zh) * | 2018-01-22 | 2018-07-06 | 深圳韦拓生物科技有限公司 | 一种人胚胎体外培养液及培养系统 |
CN108251353B (zh) * | 2018-01-22 | 2020-12-08 | 深圳韦拓生物科技有限公司 | 一种人胚胎体外培养液及培养系统 |
CN108823150A (zh) * | 2018-05-16 | 2018-11-16 | 瑞柏生物(中国)股份有限公司 | 一种输卵管缓冲培养液及其制备方法 |
CN108753690A (zh) * | 2018-06-05 | 2018-11-06 | 瑞柏生物(中国)股份有限公司 | 一种一步培养液及其制备方法 |
CN108753691A (zh) * | 2018-06-05 | 2018-11-06 | 瑞柏生物(中国)股份有限公司 | 一种囊胚培养液及其制备方法 |
CN110669724A (zh) * | 2019-11-08 | 2020-01-10 | 广州达瑞生殖技术有限公司 | 一种囊胚培养液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104140949B (zh) | 2017-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104140949A (zh) | 囊胚培养液及其制备方法 | |
CN104140950A (zh) | 卵裂培养液及其制备方法 | |
CN101760442B (zh) | 适于mdck细胞大规模贴壁培养和单细胞悬浮培养的无血清培养基 | |
CN104164401A (zh) | 精子洗涤液及其制备方法 | |
CN108251353A (zh) | 一种人胚胎体外培养液及培养系统 | |
CN104140948A (zh) | 卵子与胚胎处理液及其制备方法 | |
CN109628380A (zh) | 一种人体外受精液及其制备方法 | |
CN104140952A (zh) | 透明质酸酶及其制备方法 | |
CN106237339B (zh) | 一种冻干疫苗耐热保护剂及其制备方法和应用 | |
CN109337862A (zh) | 一种精子洗涤液及其制备方法和应用 | |
Kawai et al. | Tissue culture of Aloe arborescens Miller var. natalensis Berger | |
CN104164400A (zh) | 体外受精液及其制备方法 | |
CN104839146A (zh) | 组合物及其用途、胎盘保存制剂及其制备方法 | |
CN104130974A (zh) | 精子制动液及其制备方法 | |
CN105886422B (zh) | 枯草芽孢杆菌by7及其降解残饵和氨氮的应用 | |
CN105454220B (zh) | 一种胎盘保存方法、胎盘保存液及其制备方法 | |
CN110229784A (zh) | 一种去除死肝细胞的分离液及利用其去除死肝细胞的方法 | |
CN110643569A (zh) | 一种颗粒细胞剥离液及其制备方法 | |
CN110669724A (zh) | 一种囊胚培养液及其制备方法 | |
CN103911423B (zh) | 一种抗菌肽活性检测试剂盒及检测方法 | |
CN101921719A (zh) | 军团菌运送增菌培养基 | |
CN110452868A (zh) | 一种一步式胚胎培养液 | |
CN109355254A (zh) | 一种提取收集活细胞用的细胞缓冲液及其配制方法 | |
CN104740627B (zh) | 一种兽用伪狂犬弱毒活疫苗的规模化生产方法 | |
CN105255827B (zh) | 一种用于鲆鲽鱼类淋巴细胞增殖的培养基 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Weihua Inventor after: Lv Ruju Inventor after: Liu Meijing Inventor after: Lv Xinrong Inventor after: Wang Xiaolin Inventor after: Lu Bin Inventor after: Ma Yiwen Inventor after: Tian Yan Inventor before: Wang Weihua Inventor before: Lv Ruju Inventor before: Liu Meijing Inventor before: Zhuang Wei Inventor before: Wang Yingchao |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220726 Address after: 264210 No. 18-5 and 9, Xingshan Road, chucun Town, torch high tech Industrial Development Zone, Weihai City, Shandong Province Patentee after: Shandong Weigao Ruisheng Medical Instrument Co.,Ltd. Address before: 264209 No. 18-5, Xingshan Road, high tech Industrial Development Zone, Weihai City, Shandong Province Patentee before: SHANDONG WEGO NEW LIFE MEDICAL DEVICES CO.,LTD. |
|
TR01 | Transfer of patent right |